Impact of COVID‐19 on access to healthcare in low‐ and middle‐income countries: Current evidence and future recommendations
Melody Okereke(University of Ilorin), Don Eliseo Lucero‐Prisno(Bukidnon State University), Nelson Ashinedu Ukor(University of Port Harcourt), Isaac Olushola Ogunkola(University of Calabar), Greatman Owhor(University of Port Harcourt), Eseosa Favour Iyagbaye(University of Benin), Yusuff Adebayo Adebisi(University of Catania)
Cited by 172
Related Papers
Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
|Cancers|2022|303
Updated epidemiology of gastrointestinal cancers in East Asia
|Nature Reviews Gastroenterology & Hepatology|2023|258
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
|The Lancet Haematology|2022|208
The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries
|Tropical Medicine and Health|2021|153
Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis
|Journal of Hematology & Oncology|2022|137